These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 6177408

  • 41. Bleomycin, vinblastine, and cis-platinum in the treatment of advanced endodermal sinus tumor.
    Julian CG, Barrett JM, Richardson RL, Greco FA.
    Obstet Gynecol; 1980 Sep; 56(3):396-401. PubMed ID: 6158721
    [Abstract] [Full Text] [Related]

  • 42. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
    Luikart SD, Kennealey GT, Kirkwood JM.
    J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
    [Abstract] [Full Text] [Related]

  • 43. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ, Kwong R, Lange PH, Fraley EE, Kennedy BJ.
    Cancer Treat Rep; 1980 Mar; 64(2-3):331-4. PubMed ID: 6157467
    [Abstract] [Full Text] [Related]

  • 44. Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B.
    Carey RW, Anderson JR, Green M, Ellison RR, Nathanson L, Kennedy BJ.
    Cancer Treat Rep; 1986 Mar; 70(3):329-31. PubMed ID: 2420443
    [No Abstract] [Full Text] [Related]

  • 45. [Modern chemotherapy of a malignant testicular tumors (author's transl)].
    Arnold H, Fiebig HH.
    Radiologe; 1981 Sep; 21(9):421-30. PubMed ID: 6170087
    [Abstract] [Full Text] [Related]

  • 46. Combination chemotherapy with cis-dichlorodiammineplatinum(II) in disseminated testicular cancer.
    Einhorn LH.
    Cancer Treat Rep; 1979 Sep; 63(9-10):1659-62. PubMed ID: 91434
    [No Abstract] [Full Text] [Related]

  • 47. Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma.
    Nathanson L, Kaufman SD, Carey RW.
    Cancer; 1981 Sep 15; 48(6):1290-4. PubMed ID: 6168365
    [Abstract] [Full Text] [Related]

  • 48. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R, Speyer JL, Green M, Blum R, Wernz JC, Muggia FM.
    Cancer Treat Rep; 1987 Sep 15; 71(9):877-8. PubMed ID: 3621224
    [No Abstract] [Full Text] [Related]

  • 49. [Phase III study of cisplatin on gynecological malignancy].
    Chen JT, Takizawa K, Kawana T, Kawagoe K, Yoshida R, Yoshikawa H, Mizuno M, Sakamoto S.
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr 20; 17(3):710-9. PubMed ID: 6182259
    [No Abstract] [Full Text] [Related]

  • 50. A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.
    Gentile PS, Epremian BE, Seeger J, Hamm JT, Sheth SP.
    Am J Clin Oncol; 1988 Dec 20; 11(6):666-8. PubMed ID: 2461074
    [Abstract] [Full Text] [Related]

  • 51. Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin.
    York RM, Lawson DH, McKay J.
    Cancer; 1983 Dec 15; 52(12):2220-2. PubMed ID: 6196103
    [Abstract] [Full Text] [Related]

  • 52. Combination chemotherapy with vinblastine, bleomycin and methotrexate in DTIC-resistant metastatic melanoma.
    Porcile G, Musso M, Boccardo F, Rosso R, Santi L.
    Tumori; 1979 Apr 30; 65(2):237-40. PubMed ID: 88784
    [Abstract] [Full Text] [Related]

  • 53. PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study.
    Voigt H, Kleeberg UR.
    Cancer; 1984 May 15; 53(10):2058-62. PubMed ID: 6231091
    [Abstract] [Full Text] [Related]

  • 54. [Clinical trials of supplementary chemotherapy in cases of malignant melanoma of the skin with unfavorable prognosis after surgical treatment].
    Dobrek Z.
    Wiad Lek; 1987 Feb 15; 40(4):237-41. PubMed ID: 3617746
    [No Abstract] [Full Text] [Related]

  • 55. Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).
    Samson MK, Baker LH, Devos JM, Buroker TR, Izbicki RM, Vaitkevicius VK.
    Cancer Treat Rep; 1976 Jan 15; 60(1):91-7. PubMed ID: 63332
    [Abstract] [Full Text] [Related]

  • 56. Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
    Morton RF, Creagan ET, Veeder MH, Elson DL, Laurie JA, Nelimark RA, Chang MN.
    Cancer Treat Rep; 1987 Apr 15; 71(4):429-30. PubMed ID: 3548962
    [No Abstract] [Full Text] [Related]

  • 57. Iv hyperalimentation and chemotherapy for stage III testicular cancer: a randomized study.
    Samuels ML, Selig DE, Ogden S, Grant C, Brown B.
    Cancer Treat Rep; 1981 Apr 15; 65(7-8):615-27. PubMed ID: 6166374
    [No Abstract] [Full Text] [Related]

  • 58. Metastatic potential of melanoma cells is not affected by electrochemotherapy.
    Todorovic V, Sersa G, Mlakar V, Glavac D, Flisar K, Cemazar M.
    Melanoma Res; 2011 Jun 15; 21(3):196-205. PubMed ID: 20216102
    [Abstract] [Full Text] [Related]

  • 59. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.
    Carlson RW, Dorfman RF, Sikic BI.
    Cancer; 1990 Nov 15; 66(10):2092-4. PubMed ID: 1699650
    [Abstract] [Full Text] [Related]

  • 60. Chemotherapy of disseminated testicular cancer. A random prospective study.
    Einhorn LH, Williams SD.
    Cancer; 1980 Sep 15; 46(6):1339-44. PubMed ID: 6158370
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.